{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:03:04Z","timestamp":1791669784467,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40257-023-00776-6","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T08:02:15Z","timestamp":1683100935000},"page":"637-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis"],"prefix":"10.1007","volume":"24","author":[{"given":"Bertrand ShengYang","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy H.","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehena","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus Chong En","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Jui Lin","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Wei","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-5810","authenticated-orcid":false,"given":"Haur Yueh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"issue":"4","key":"776_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/s1085-5629(96)80038-1","volume":"15","author":"H Bocquet","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15(4):250\u20137. https:\/\/doi.org\/10.1016\/s1085-5629(96)80038-1.","journal-title":"Semin Cutan Med Surg"},{"issue":"4","key":"776_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/jdv.12419","volume":"29","author":"D Picard","year":"2015","unstructured":"Picard D, Vellar M, Janela B, Roussel A, Joly P, Musette P. Recurrence of drug-induced reactions in DRESS patients. J Eur Acad Dermatol Venereol. 2015;29(4):801\u20134. https:\/\/doi.org\/10.1111\/jdv.12419.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"776_CR3","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","volume":"22","author":"CC Chiou","year":"2008","unstructured":"Chiou CC, Yang LC, Hung SI, et al. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol. 2008;22(9):1044\u20139. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02585.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"776_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.47102\/annals-acadmedsg.V47N11p492","volume":"47","author":"BS Lian","year":"2018","unstructured":"Lian BS, Busmanis I, Lee HY. Relapsing course of sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) complicated by alopecia universalis and vitiligo. Ann Acad Med Singap. 2018;47(11):492\u20133.","journal-title":"Ann Acad Med Singap"},{"issue":"12","key":"776_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","volume":"146","author":"YC Chen","year":"2010","unstructured":"Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol. 2010;146(12):1373. https:\/\/doi.org\/10.1001\/archdermatol.2010.198.","journal-title":"Arch Dermatol"},{"issue":"11","key":"776_CR6","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005;102(11):4134\u20139. https:\/\/doi.org\/10.1073\/pnas.0409500102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"776_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/tpj.2013.40","volume":"14","author":"E Genin","year":"2014","unstructured":"Genin E, Chen DP, Hung SI, et al. HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics J. 2014;14(3):281\u20138. https:\/\/doi.org\/10.1038\/tpj.2013.40.","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"776_CR8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jaci.2014.09.041","volume":"135","author":"CH Lin","year":"2015","unstructured":"Lin CH, Chen JK, Ko TM, et al. Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction. J Allergy Clin Immunol. 2015;135(4):1063\u20135. https:\/\/doi.org\/10.1016\/j.jaci.2014.09.041.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"776_CR9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jaip.2016.10.009","volume":"5","author":"K Hansel","year":"2017","unstructured":"Hansel K, Bellini V, Bianchi L, Brozzi J, Stingeni L. Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: an immunohistochemical study. J Allergy Clin Immunol Pract. 2017;5(3):808\u201310. https:\/\/doi.org\/10.1016\/j.jaip.2016.10.009.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"776_CR10","doi-asserted-by":"publisher","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","volume":"182","author":"R Takahashi","year":"2009","unstructured":"Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol. 2009;182(12):8071\u20139. https:\/\/doi.org\/10.4049\/jimmunol.0804002.","journal-title":"J Immunol"},{"issue":"6","key":"776_CR11","first-page":"425","volume":"24","author":"R Caba\u00f1as","year":"2014","unstructured":"Caba\u00f1as R, Calderon O, Ramirez E, et al. Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients. J Investig Allergol Clin Immunol. 2014;24(6):425\u201330.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"11","key":"776_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.annder.2010.04.024","volume":"137","author":"V Descamps","year":"2010","unstructured":"Descamps V, Ben Sa\u00efd B, Sassolas B, et al. Management of drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol. 2010;137(11):703\u20138. https:\/\/doi.org\/10.1016\/j.annder.2010.04.024.","journal-title":"Ann Dermatol Venereol"},{"issue":"3","key":"776_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","volume":"68","author":"T Shiohara","year":"2019","unstructured":"Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019. Allergol Int. 2019;68(3):301\u20138. https:\/\/doi.org\/10.1016\/j.alit.2019.03.006.","journal-title":"Allergol Int"},{"issue":"5","key":"776_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jaad.2012.10.017","volume":"68","author":"Y Ushigome","year":"2013","unstructured":"Ushigome Y, Kano Y, Ishida T, Hirahara K, Shiohara T. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. JAMA Dermatol. 2013;68(5):721\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2012.10.017.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"776_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1468-3083.2012.04547.x","volume":"27","author":"H Uhara","year":"2013","unstructured":"Uhara H, Saiki M, Kawachi S, Ashida A, Oguchi S, Okuyama R. Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids. J Eur Acad Dermatol Venereol. 2013;27(6):722\u20136. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04547.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"776_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","volume":"169","author":"SH Kardaun","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071\u201380. https:\/\/doi.org\/10.1111\/bjd.12501.","journal-title":"Br J Dermatol"},{"key":"776_CR17","volume-title":"Stata statistical software: release 14","author":"StataCorp","year":"2015","unstructured":"StataCorp. Stata statistical software: release 14. College Station: StataCorp LP; 2015."},{"issue":"9","key":"776_CR18","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/ijd.13667","volume":"56","author":"JY Lee","year":"2017","unstructured":"Lee JY, Lee SY, Hahm JE, Ha JW, Kim CW, Kim SS. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea. Int J Dermatol. 2017;56(9):944\u201351. https:\/\/doi.org\/10.1111\/ijd.13667.","journal-title":"Int J Dermatol"},{"issue":"2","key":"776_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaad.2014.10.032","volume":"72","author":"E Funck-Brentano","year":"2015","unstructured":"Funck-Brentano E, Duong TA, Bouvresse S, et al. Therapeutic management of DRESS: a retrospective study of 38 cases. JAMA Dermatol. 2015;72(2):246\u201352. https:\/\/doi.org\/10.1016\/j.jaad.2014.10.032.","journal-title":"JAMA Dermatol"},{"key":"776_CR20","first-page":"7","volume":"20","author":"S Um","year":"2010","unstructured":"Um S, Lee S, Kim Y, Kim K, Son C, Lee M. Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol. 2010;20:7.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"776_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.aller.2013.08.003","volume":"43","author":"YH Nam","year":"2015","unstructured":"Nam YH, Park MR, Nam HJ, et al. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised. Allergol Immunopathol. 2015;43(1):19\u201324. https:\/\/doi.org\/10.1016\/j.aller.2013.08.003.","journal-title":"Allergol Immunopathol"},{"key":"776_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2021.02.002","author":"C Brin","year":"2021","unstructured":"Brin C, Bernigaud C, Hua C, et al. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): a monocenter retrospective study of 20 cases. Ann Dermatol Venereol. 2021. https:\/\/doi.org\/10.1016\/j.annder.2021.02.002.","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"776_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med. 2002;346(5):321\u20137. https:\/\/doi.org\/10.1056\/NEJMoa011592.","journal-title":"N Engl J Med"},{"issue":"6","key":"776_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1046\/j.1365-2133.1996.d01-912.x","volume":"134","author":"S Chopra","year":"1996","unstructured":"Chopra S, Levell N, Cowley G, Gilkes J. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol. 1996;134(6):1109\u201312.","journal-title":"Br J Dermatol"},{"issue":"3","key":"776_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1684\/ejd.2011.1300","volume":"21","author":"J Natkunarajah","year":"2011","unstructured":"Natkunarajah J, Goolamali S, Craythorne E, et al. Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone. Eur J Dermatol. 2011;21(3):385\u201391. https:\/\/doi.org\/10.1684\/ejd.2011.1300.","journal-title":"Eur J Dermatol"},{"issue":"1","key":"776_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/archderm.145.1.67","volume":"145","author":"M Eshki","year":"2009","unstructured":"Eshki M, Allanore L, Musette P, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol. 2009;145(1):67\u201372. https:\/\/doi.org\/10.1001\/archderm.145.1.67.","journal-title":"Arch Dermatol"},{"issue":"3","key":"776_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","volume":"80","author":"Y Mizukawa","year":"2019","unstructured":"Mizukawa Y, Hirahara K, Kano Y, Shiohara T. Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. J Am Acad Dermatol. 2019;80(3):670\u201382. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.052.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"776_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/1346-8138.15294","volume":"47","author":"M Tohyama","year":"2020","unstructured":"Tohyama M, Hashimoto K, Oda F, Namba C, Sayama K. Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. J Dermatol. 2020;47(5):476\u201382. https:\/\/doi.org\/10.1111\/1346-8138.15294.","journal-title":"J Dermatol"},{"issue":"6","key":"776_CR29","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.anai.2021.08.012","volume":"127","author":"HJ Su","year":"2021","unstructured":"Su HJ, Chen CB, Yeh TY, Chung WH. Successful treatment of corticosteroid-dependent drug reaction with eosinophilia and systemic symptoms with cyclosporine. Ann Allergy Asthma Immunol. 2021;127(6):674\u201381. https:\/\/doi.org\/10.1016\/j.anai.2021.08.012.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"776_CR30","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.jdcr.2019.07.004","volume":"5","author":"WE Damsky","year":"2019","unstructured":"Damsky WE, Vesely MD, Lee AI, et al. Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib. JAAD Case Rep. 2019;5(12):1018\u201326. https:\/\/doi.org\/10.1016\/j.jdcr.2019.07.004.","journal-title":"JAAD Case Rep."},{"issue":"7","key":"776_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/17425255.2017.1297422","volume":"13","author":"T Shiohara","year":"2017","unstructured":"Shiohara T, Kano Y, Hirahara K, Aoyama Y. Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS). Expert Opin Drug Metabol Toxicol. 2017;13(7):701\u20134. https:\/\/doi.org\/10.1080\/17425255.2017.1297422.","journal-title":"Expert Opin Drug Metabol Toxicol"},{"issue":"4","key":"776_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.alit.2016.04.001","volume":"65","author":"A Hiransuthikul","year":"2016","unstructured":"Hiransuthikul A, Rattananupong T, Klaewsongkram J, Rerknimitr P, Pongprutthipan M, Ruxrungtham K. Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS): 11 years retrospective study in Thailand. Allergol Int. 2016;65(4):432\u20138. https:\/\/doi.org\/10.1016\/j.alit.2016.04.001.","journal-title":"Allergol Int"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00776-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-023-00776-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00776-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T12:31:39Z","timestamp":1687782699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-023-00776-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1007\/s40257-023-00776-6","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"assertion":[{"value":"26 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Bertrand ShengYang Lian, Judy H. Ha, Rehena Sultana, Linus\u00a0Chong En Chan, Karen Jui Lin Choo, Yi Wei Yeo, and Haur Yueh Lee have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the SingHealth Centralised Institutional Review Board (Ref. 2014\/2011).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available because of privacy or ethical restrictions.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Drafting of the manuscript: BSYL, JHH. Data collection\/analysis: BSYL, JHH, RS, LCEC. Critical revision of the manuscript: BSYL, RS, KJLC, YWY, HYL. Supervision: HYL. All authors have read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}